[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate

Norgestimate; LC-ESI-ITFT; MS2; CE: 10%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 20%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+

Norgestimate; LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+

Norgestimate; LC-ESI-QTOF; MS2; CE: Ramp 23.0-34.5 eV; R=35000; [M+H]+